Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - Enochian Biosciences Inc | Financial_Report.xls |
| EX-32.2 - CERTIFICATION - Enochian Biosciences Inc | f10q0314ex32ii_dandritbio.htm |
| EX-31.2 - CERTIFICATION - Enochian Biosciences Inc | f10q0314ex31ii_dandritbio.htm |
| EX-10.7 - LETTER OF SUPPORT OF PASECO APS RELATED TO COMMITTED 2M DKK IN ADDITIONAL FINANCING, DATED MAY 2, 2014. - Enochian Biosciences Inc | f10q0314ex10vii_dandritbio.htm |
| EX-31.1 - CERTIFICATION - Enochian Biosciences Inc | f10q0314ex31i_dandritbio.htm |
| 10-Q - QUARTERLY REPORT - Enochian Biosciences Inc | f10q0314_dandritbiotech.htm |
| EX-10.6 - LOAN AGREEMENT BY AND BETWEEN DANDRIT DENMARK AND PASECO APS DATED APRIL 29, 2014. - Enochian Biosciences Inc | f10q0314ex10vi_dandritbio.htm |
Exhibit 32.1
Certification of Principal Executive Officer
Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002
In connection with the Quarterly Report of DanDrit Biotech USA, Inc. (the "Company") on Form 10-Q for the period ending March 31, 2014 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Eric J. Leire, certify, pursuant to 18 U.S.C. ss. 1350, as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:
(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
/s/ Eric J. Leire
|
|
|
Eric J. Leire
|
|
|
Principal Executive Officer
|
|
|
May 14, 2014
|